Scrip Asks…What Does 2021 Hold for Biopharma? Part 5: Business Environment and Strategy

Scrip

"A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead."

Read the article

Related Contacts
Kenneth Krisko Partner, Reston